The Valley Desk

ReviewClinical infectious diseases : an official publication of the Infectious Diseases Society of AmericaPublished

2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Treatment and Management of COVID-19: Pemivibart for Pre-exposure Prophylaxis, Vilobelimab for Critical Illness, and Abatacept or Infliximab for Severe or Critical Illness

Read the publication ↗ Open access copy ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Children’s Hospital of Philadelphia, University of Pennsylvania. Affiliation source

Publication record

Type
Review
Venue
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published
Subject terms
Humans; Critical Illness; Immunocompromised Host; Pregnancy; Adult; Societies, Medical; Female; Pre-Exposure Prophylaxis; Infliximab; COVID-19; SARS-CoV-2; COVID-19 Drug Treatment
PubMed ID
40757658
PubMed Central ID
PMC12809781
Added to directory
Source checked

Report a correction or request removal